Category Archives: Biotechnology

Home / Biotechnology
2 Posts

Marc Beer has been serving in the biotechnology sector for over 25 years, and he has helped to grow many different companies during that time. He studied at Miami University and received his Bachelor of Science degree in business in 1987. He went to work in the pharmaceutical sales sector after finishing college and eventually worked with Genzyme as its vice president of global marketing. Beer was able to make a huge difference by addressing the needs of an underserved group of people through his marketing efforts and was forever changed by doing so. 

During the earlier part of the 2000s, Marc Beer decided to start up his first company, which was named VIA CELL. This biotechnology company had 300 employees, and it went public during the mid-2000s. It focused on collecting and preserving umbilical cord blood stem cells, which could be used to treat various ailments that people suffered from. He eventually sold the company for $300 million to PerkinElmer right before his wife passed away from a pulmonary embolism. Learn more: https://www.bloomberg.com/research/stocks/people/person.asp?personId=1285777&privcapId=47636573

Marc Beer focused on raising his children after his wife passed away, and it was one of his kids who inspired him to get back to work a couple of years later. He had always taught his children to live their lives with purpose, and his daughter reminded him of his own words. He got back to work, and some years later, he helped to found Renovia. He continues to serve as the company’s chairman and CEO today. The company was started up when Beer partnered up with Yolanda Lorie and Dr. Iglesias in order to create therapeutic diagnostic devices for women who suffer from pelvic floor diseases. 

In 2018, all of the hard work of Marc Beer paid off when Renovia came out with its first product, which is named Leva. The Food and Drug Administration approved Leva, and he was able to go on to get venture capital funding and a Series B round of funding. Beer commented on the Series B funding by saying that his company was thrilled to be supported by a group of the top healthcare investors. He went on to talk more about the details of his company and how it will help to lower the cost of healthcare for women in the future. 

Marc Beer serves Renovia as its chief executive officer and chairman, and he has been successfully running the company for years. In the past, he has also served with Good Start Genetics, Inc. as its founding chairman of the board as well as its chairman of the compensation committee. He also served with the Miami University Business Advisory Council as a member and continues to do what he feels is right by helping to improve the biotechnology industry.

Follow Marc Beer on Facebook

The pharmaceutical industry is constantly changing lives as new ways to treat and sometimes even cure diseases are being discovered every single day. While coming up with the product is important, it means nothing unless someone is able to present it in order to get FDA approval so it can be brought to market. This is where people such as Marc Beer come in as the Chief Executive Officer of Renovia. While he may not be the one that is creating the breakthroughs himself, he is the one that is making sure that the company has enough capital to fund their projects and then get them marketed after approval.

Modern medicine is something that has been attracting the attention of Marc Beer for many years as it was capable of doing a lot more than just healing the sick. It has the potential to change how we live our lives completely. There are people alive today that Marc Beer knows would have been given a death sentence as the outcome of their disease just 100 years ago. Some of these illnesses would include heart disease, diabetes, and even cancer. While these diseases can still be deadly even today, the prognosis is much better thanks to modern medicine that is available today. Being able to be part of the process is something that he has always hoped to be able to do and has been doing for the past two decades and more.

While Renovia is not turning a profit yet, Marc Beer has still been able to collect venture capital to further research the products that they are working on that are related to pelvic floor disorder. He predicts that it will take about a decade to start turning a profit at the company that he co-founded in 2016. Their Series B funding just completed more than $40 million in raised capital from investors. While the company is dependent on the capital of others at the moment, Marc Beer hopes to be able to turn it profitable in the long run.

While working for large pharmaceutical companies, Marc Beer did not have to fear that the company wouldn’t exist the next day after going broke. This is a concern when working at a smaller company like the ones that he has helped to found over the years. Despite the fact that working with smaller companies is risky, it is something that he enjoys as a career and he has grown a reputation surrounding the success that he has had. There were times at some of these companies where he feared he would not be able to continue operating, but he had been able to turn it around thanks to the strong team that works with him. Learn more: http://inspirery.com/interview-with-marc-beer/